Intrarenal angiotensin-converting enzyme induces hypertension in response to angiotensin I infusion

Journal of the American Society of Nephrology

Volumn 22, Issue 3, 2011, Pages 449-459

  Gonzalez Villalobos, Romer A ^a,b   Billet, Sandrine ^b   Kim, Catherine ^a   Satou, Ryousuke ^a   Fuchs, Sebastien ^b   Bernstein, Kenneth E ^b   Navar, L Gabriel ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN I; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; GENETIC RECOMBINATION; HYPERTENSION; KIDNEY CONCENTRATING CAPACITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; URINARY EXCRETION;

EID: 79952340670     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010060624     Document Type: Article

References (54)

1. Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A, Luomanmaki K, Dahlof B, de Faire U, Morlin C, Karlberg BE, Wester PO, Bjorck JE: Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial. Lancet 353: 611-616, 1999 (Pubitemid 29087980)
2. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342: 145-153, 2000
3. Giles TD: Renin-angiotensin system modulation for treatment and prevention of cardiovascular diseases: Toward an optimal therapeutic strategy. Rev Cardiovasc Med 8 [Suppl 2]: S14-S21, 2007
4. Investigators O, Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C: Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358: 1547-1559, 2008 (Pubitemid 351522739)
5. Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM: Renin-angiotensin system and cardiovascular risk. Lancet 369: 1208-1219, 2007 (Pubitemid 46527856)
6. Atlas SA: The renin-angiotensin aldosterone system: Pathophysiological role and pharmacologic inhibition. J Manag Care Pharm 13: 9-20, 2007
7. Mitchell KD, Braam B, Navar LG: Hypertensinogenic mechanisms mediated by renal actions of renin-angiotensin system. Hypertension 19: I18-I27, 1992
8. Navar LG, Harrison-Bernard LM, Nishiyama A, Kobori H: Regulation of intrarenal angiotensin II in hypertension. Hypertension 39: 316-322, 2002 (Pubitemid 34165142)
9. Hall JE, Granger JP, Hester RL, Coleman TG, Smith MJ Jr., Cross RB: Mechanisms of escape from sodium retention during angiotensin II hypertension. Am J Physiol 246: F627-F634, 1984 (Pubitemid 14110779)
10. Wang CT, Chin SY, Navar LG: Impairment of pressure-natriuresis and renal autoregulation in ANG II-infused hypertensive rats. Am J Physiol Renal Physiol 279: F319-F325, 2000
11. Zhao D, Seth DM, Navar LG: Enhanced distal nephron sodium reabsorption in chronic angiotensin II-infused mice. Hypertension 54: 120-126, 2009
12. Guyton AC: Abnormal renal function and autoregulation in essential hypertension. Hypertension 18: III49-III53, 1991
13. Johnson RJ, Feig DI, Nakagawa T, Sanchez-Lozada LG, Rodriguez-Iturbe B: Pathogenesis of essential hypertension: Historical paradigms and modern insights. J Hypertens 26: 381-391, 2008 (Pubitemid 351317242)
14. Navar LG, Zou L, Von Thun A, Tarng Wang C, Imig JD, Mitchell KD: Unraveling the mystery of goldblatt hypertension. News Physiol Sci 13: 170-176, 1998
15. Campbell DJ, Alexiou T, Xiao HD, Fuchs S, McKinley MJ, Corvol P, Bernstein KE: Effect of reduced angiotensin-converting enzyme gene expression and angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptide levels in mice. Hypertension 43: 854-859, 2004 (Pubitemid 38405600)
16. Tian B, Meng QC, Chen YF, Krege JH, Smithies O, Oparil S: Blood pressures and cardiovascular homeostasis in mice having reduced or absent angiotensin-converting enzyme gene function. Hypertension 30: 128-133, 1997 (Pubitemid 27306358)
17. Gonzalez-Villalobos RA, Satou R, Seth DM, Semprun-Prieto LC, Katsurada A, Kobori H, Navar LG: Angiotensin-converting enzyme-derived angiotensin II formation during angiotensin II-induced hypertension. Hypertension 53: 351-355, 2009
18. Gonzalez-Villalobos RA, Seth DM, Satou R, Horton H, Ohashi N, Miyata K, Katsurada A, Tran DV, Kobori H, Navar LG: Intrarenal angiotensin II and angiotensinogen augmentation in chronic angiotensin II-infused mice. Am J Physiol Renal Physiol 295: F772-F779, 2008
19. Shao X, Johnson JE, Richardson JA, Hiesberger T, Igarashi P: A minimal Ksp-cadherin promoter linked to a green fluorescent protein reporter gene exhibits tissue-specific expression in the developing kidney and genitourinary tract. J Am Soc Nephrol 13: 1824-1836, 2002
20. Esther CR Jr., Howard TE, Marino EM, Goddard JM, Capecchi MR, Bernstein KE: Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab Invest 74: 953-965, 1996 (Pubitemid 26152664)
21. Esther CR, Marino EM, Howard TE, Machaud A, Corvol P, Capecchi MR, Bernstein KE: The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice. J Clin Invest 99: 2375-2385, 1997 (Pubitemid 27227714)
22. Gonzalez-Villalobos RA, Satou R, Ohashi N, Semprun-Prieto LC, Katsurada A, Kim C, Upchurch GM, Prieto MC, Kobori H, Navar LG: Intrarenal mouse renin-angiotensin system during ANG II-induced hypertension and ACE inhibition. Am J Physiol Renal Physiol 298: F150-F157, 2010
23. Ingelfinger JR, Jung F, Diamant D, Haveran L, Lee E, Brem A, Tang SS: Rat proximal tubule cell line transformed with origin-defective SV40 DNA: Autocrine ANG II feedback. Am J Physiol 276: F218-F227, 1999 (Pubitemid 29102286)
24. Moe OW, Ujiie K, Star RA, Miller RT, Widell J, Alpern RJ, Henrich WL: Renin expression in renal proximal tubule. J Clin Invest 91: 774-779, 1993
25. Koike G, Krieger JE, Jacob HJ, Mukoyama M, Pratt RE, Dzau VJ: Angiotensin converting enzyme and genetic hypertension: Cloning of rat cDNAs and characterization of the enzyme. Biochem Biophys Res Commun 198: 380-386, 1994
26. Harrison-Bernard LM, Zhuo J, Kobori H, Ohishi M, Navar LG: Intrarenal AT(1) receptor and ACE binding in ANG II-induced hypertensive rats. Am J Physiol Renal Physiol 282: F19-F25, 2002 (Pubitemid 34654195)
27. Rohrwasser A, Morgan T, Dillon HF, Zhao L, Callaway CW, Hillas E, Zhang S, Cheng T, Inagami T, Ward K, Terreros DA, Lalouel JM: Elements of a paracrine tubular renin-angiotensin system along the entire nephron. Hypertension 34: 1265-1274, 1999 (Pubitemid 30002393)
28. Rohrwasser A, Ishigami T, Gociman B, Lantelme P, Morgan T, Cheng T, Hillas E, Zhang S, Ward K, Bloch-Faure M, Meneton P, Lalouel JM: Renin and kallikrein in connecting tubule of mouse. Kidney Int 64: 2155-2162, 2003 (Pubitemid 37449550)
29. Kobori H, Ozawa Y, Satou R, Katsurada A, Miyata K, Ohashi N, Hase N, Suzaki Y, Sigmund CD, Navar LG: Kidney-specific enhancement of ANG II stimulates endogenous intrarenal angiotensinogen in gene-targeted mice. Am J Physiol Renal Physiol 293: F938-F945, 2007 (Pubitemid 47403366)
30. Lavoie JL, Lake-Bruse KD, Sigmund CD: Increased blood pressure in transgenic mice expressing both human renin and angiotensinogen in the renal proximal tubule. Am J Physiol Renal Physiol 286: F965-F971, 2004 (Pubitemid 38508997)
31. Sachetelli S, Liu Q, Zhang SL, Liu F, Hsieh TJ, Brezniceanu ML, Guo DF, Filep JG, Ingelfinger JR, Sigmund CD, Hamet P, Chan JS: RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney. Kidney Int 69: 1016-1023, 2006 (Pubitemid 43372176)
32. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, Kim HS, Smithies O, Le TH, Coffman TM: Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A 103: 17985-17990, 2006 (Pubitemid 44852272)
33. Zhuo J, Ohishi M, Mendelsohn FA: Roles of AT1 and AT2 receptors in the hypertensive Ren-2 gene transgenic rat kidney. Hypertension 33: 347-353, 1999 (Pubitemid 29065683)
34. Kobori H, Alper AB Jr., Shenava R, Katsurada A, Saito T, Ohashi N, Urushihara M, Miyata K, Satou R, Hamm LL, Navar LG: Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients. Hypertension 53: 344-350, 2009
35. Kobori H, Nangaku M, Navar LG, Nishiyama A: The intrarenal renin-angiotensin system: From physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59: 251-287, 2007 (Pubitemid 47481436)
36. Komlosi P, Fuson AL, Fintha A, Peti-Peterdi J, Rosivall L, Warnock DG, Bell PD: Angiotensin I conversion to angiotensin II stimulates cortical collecting duct sodium transport. Hypertension 42: 195-199, 2003 (Pubitemid 36944596)
37. Kawada N, Imai E, Karber A, Welch WJ, Wilcox CS: A mouse model of angiotensin II slow pressor response: Role of oxidative stress. J Am Soc Nephrol 13: 2860-2868, 2002 (Pubitemid 35386905)
38. Xiao HD, Fuchs S, Cole JM, Disher KM, Sutliff RL, Bernstein KE: Role of bradykinin in angiotensin-converting enzyme knockout mice. Am J Physiol 284: H1969-H1977, 2003 (Pubitemid 36622406)
39. Cervenka L, Maly J, Karasova L, Simova M, Vitko S, Hellerova S, Heller J, El-Dahr SS: Angiotensin II-induced hypertension in bradykinin B2 receptor knockout mice. Hypertension 37: 967-973, 2001 (Pubitemid 32221621)
40. Kim HS, Krege JH, Kluckman KD, Hagaman JR, Hodgin JB, Best CF, Jennette JC, Coffman TM, Maeda N, Smithies O: Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci U S A 92: 2735-2739, 1995
41. Niimura F, Labosky PA, Kakuchi J, Okubo S, Yoshida H, Oikawa T, Ichiki T, Naftilan AJ, Fogo A, Inagami T, Hogan BLM, lchikawa I: Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J Clin Invest 96: 2947-2954, 1995
42. Crowley SD, Gurley SB, Oliverio MI, Pazmino AK, Griffiths R, Flannery PJ, Spurney RF, Kim HS, Smithies O, Le TH, Coffman TM: Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J Clin Invest 115: 1092-1099, 2005 (Pubitemid 40489414)
43. Shao W, Seth DM, Navar LG: Augmenation of endogenous angiotensin II levels in Val5-Ang II infused rats. JIM 56: 344-492, 2008
44. Park S, Bivona BJ, Kobori H, Seth DM, Chappell MC, Lazartigues E, Harrison-Bernard LM: Major role for ACE-independent intrarenal ANG II formation in type II diabetes. Am J Physiol Renal Physiol 298: F37-F48, 2010
45. Cole J, Quach DL, Sundaram K, Corvol P, Capecchi MR, Bernstein KE: Mice lacking endothelial angiotensin-converting enzyme have a normal blood pressure. Circ Res 90: 87-92, 2002 (Pubitemid 34074613)
46. Wang Q, Hummler E, Nussberger J, Clement S, Gabbiani G, Brunner HR, Burnier M: Blood pressure, cardiac, and renal responses to salt and deoxycorticosterone acetate in mice: Role of renin genes. J Am Soc Nephrol 13: 1509-1516, 2002 (Pubitemid 34579240)
47. Lum C, Shesely EG, Potter DL, Beierwaltes WH: Cardiovascular and renal phenotype in mice with one or two renin genes. Hypertension 43: 79-86, 2004 (Pubitemid 38031914)
48. Kobori H, Harrison-Bernard LM, Navar LG: Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension. J Am Soc Nephrol 12: 431-439, 2001 (Pubitemid 32180011)
49. Prieto-Carrasquero MC, Harrison-Bernard LM, Kobori H, Ozawa Y, Hering-Smith KS, Hamm LL, Navar LG: Enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Hypertension 44: 223-229, 2004 (Pubitemid 39014242)
50. Yun JC, Donahue JJ, Bartter FC, Kelly GD: Effect of pentobarbital anesthesia and laparotomy on plasma renin activity in the dog. Can J Physiol Pharmacol 57: 412-416, 1979 (Pubitemid 9155942)
51. Spring A, Spring G, Liebau H, Kirchner E: [Effect of thiopental anesthesia on plasma renin, adrenaline and noradrenaline in neurosurgical operations with induced hypotension]. Anaesthesist 32: 12-17, 1983
52. Walker LA, Gellai M, Valtin H: Renal response to pentobarbital anesthesia in rats: Effect of interrupting the renin-angiotensin system. J Pharmacol Exp Ther 236: 721-728, 1986 (Pubitemid 16080071)
53. Imig JD, Navar GL, Zou LX, O'Reilly KC, Allen PL, Kaysen JH, Hammond TG, Navar LG: Renal endosomes contain angiotensin peptides, converting enzyme, and AT(1A) receptors. Am J Physiol 277: F303-F311, 1999 (Pubitemid 29415150)
54. Fuchs S, Germain S, Philippe J, Corvol P, Pinet F: Expression of renin in large arteries outside the kidney revealed by human renin promoter/LacZ transgenic mouse. Am J Pathol 161: 717-725, 2002 (Pubitemid 36142180)